Reaching LDL-C Targets in Patients with Moderate, High, and Very High Risk for Cardiovascular Disease After Bariatric Surgery According to Different Guidelines

被引：0
|
作者：
Guillermo Ponce de León-Ballesteros
Hugo A. Sánchez-Aguilar
Carlos A. Aguilar-Salinas
Miguel F. Herrera
机构：
[1] ABC Medical Center,Clinic for Nutrition and Obesity
[2] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,Unidad de Investigación en Enfermedades Metabólicas
[3] Direccion de Nutricion,Department of Surgery
[4] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,undefined
[5] Tecnologico de Monterrey,undefined
[6] Escuela de Medicina y Ciencias de la Salud,undefined
[7] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran,undefined
来源：
Obesity Surgery | 2021年 / 31卷
关键词：
Hyperlipidemia; Bariatric surgery; Low-density lipoproteins; Cardiovascular risk; Roux-Y gastric bypass;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2087 / 2096
页数：9
相关论文
共 50 条
  • [1] Reaching LDL-C Targets in Patients with Moderate, High, and Very High Risk for Cardiovascular Disease After Bariatric Surgery According to Different Guidelines
    Ponce de Leon-Ballesteros, Guillermo
    Sanchez-Aguilar, Hugo A.
    Aguilar-Salinas, Carlos A.
    Herrera, Miguel F.
    OBESITY SURGERY, 2021, 31 (05) : 2087 - 2096
  • [2] ACHIEVEMENT OF LDL-C TARGETS IN CHINESE PATIENTS WITH VERY HIGH RISK ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RECEIVING INTENSIVE LIPID LOWERING THERAPY
    Cheng, Y.
    Dong, S.
    Shen, P.
    Sun, Y.
    Lin, H.
    Zhai, S.
    VALUE IN HEALTH, 2022, 25 (01) : S24 - S24
  • [3] LACKING OBSERVANCE OF THE GUIDELINES ON DYSLIPIDAEMIAS AS POSSIBLE REASON FOR LOW LDL-C GOAL ATTAINMENT IN PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK
    Mullerova, J.
    Vrablik, M.
    Sarkanova, I
    Brecikova, K.
    Tichopad, A.
    VALUE IN HEALTH, 2022, 25 (12) : S275 - S275
  • [4] Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias
    Vrablik, Michal
    Sarkanova, Ivana
    Brecikova, Katarina
    Sedova, Petra
    Satny, Martin
    Tichopad, Ales
    PLOS ONE, 2023, 18 (05):
  • [5] STATIN TREATED PATIENTS AT VERY HIGH CARDIOVASCULAR RISK IN EUROPE: ARE THE MAJORITY CLOSE TO LDL-C
    Lautsch, D.
    Gitt, A. K.
    Brudi, P.
    Vanneste, B.
    Ambegaonkar, B.
    ATHEROSCLEROSIS, 2014, 235 (02) : E35 - E35
  • [6] LDL-C TREATMENT GAPS IN STATIN-TREATED PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK IN EUROPE
    Gitt, A. K.
    Ambegaonkar, B.
    Brudi, P.
    Lautsch, D.
    ATHEROSCLEROSIS, 2014, 235 (02) : E106 - E106
  • [7] Cardiovascular Risk Patients Reaching LDL-C Target Values is worthwhile
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2021, 30 (03): : 189 - 189
  • [8] ACHIEVEMENT OF LDL-C GOALS IN PATIENTS AT MODERATE TO VERY HIGH CARDIOVASCULAR RISK ON LIPID-LOWERING DRUG THERAPY (CEPHEUS II)
    Logunova, Natalia
    Gurina, Natalia
    Boytsov, Sergey
    ATHEROSCLEROSIS, 2017, 263 : E236 - E237
  • [9] Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study
    Gavina, Cristina
    Seabra-Carvalho, Daniel
    Aguiar, Carlos
    Anastassopoulou, Anastassia
    Teixeira, Carla
    Ruivo, Jorge A.
    Almeida, Elia
    Luz-Duarte, Leonor
    Corte-Real, Ana
    Canelas-Pais, Mariana
    Taveira-Gomes, Tiago
    CLINICAL CARDIOLOGY, 2024, 47 (01)
  • [10] CONSISTENCY OF FRIEDEWALD, MARTIN/HOPKINS AND SAMSON FORMULAS FOR LDL-C CALCULATION IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS
    Basaran, O.
    Dogan, V.
    Celik, O.
    Cil, C.
    Ozlek, B.
    Ozlek, E.
    Ozdemir, I. H.
    Rencuzogullari, I.
    Karadeniz, F.
    Tekinalp, M.
    Askin, L.
    Demirelli, S.
    Gencer, E.
    Biteker, M.
    Kayikcioglu, M.
    ATHEROSCLEROSIS, 2022, 355 : E160 - E160
12345